SEC Comment Letter for Arcadia Biosciences, Inc. (RKDA) (CIK 0001469443) (RKDA) — Feb 8, 2019
Arcadia Biosciences, Inc. (RKDA) (CIK 0001469443)
Date: Feb. 8, 2019 · CIK: 0001469443 · Accession: 0000000000-19-001509
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-229047
Letter
February 6, 2019 Rajendra Ketkar President and Chief Executive Officer Arcadia Biosciences, Inc. 202 Cousteau Place Suite 105 Davis, CA 95618 Re:Arcadia Biosciences, Inc. Registration Statement on Form S-1 Filed December 27, 2018 File No. 333-229047 Dear Mr. Ketkar: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact John Dana Brown at 202-551-3859 with any questions. Sincerely, Division of Corporation Finance Office of Transportation and Leisure
Show Raw Text
February 6, 2019
Rajendra Ketkar
President and Chief Executive Officer
Arcadia Biosciences, Inc.
202 Cousteau Place
Suite 105
Davis, CA 95618
Re:Arcadia Biosciences, Inc.
Registration Statement on Form S-1
Filed December 27, 2018
File No. 333-229047
Dear Mr. Ketkar:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact John Dana Brown at 202-551-3859 with any questions.
Sincerely,
Division of Corporation Finance
Office of Transportation and Leisure